A stock solution containing 1% AZI was used to investigate the degradation kinetics of AZI. The stock solution (1 mL) was separately diluted to 10 mL using phosphate buffer solutions with different pH values (1, 3, 5, 7, 10) and incubated at 75 °C for 2 h, 4 h, 6 h, 12 h and 24 h. The incubate solutions (0.5 mL) was then diluted ten times with the mobile phase to obtain test solutions. The actual pH values of each test solution were monitored. Moreover, the concentration of AZI (CAZI) at each time points was quantified by HPLC-UV. Then, lnCAZI was plotted against time (t) to analyze the apparent hydrolysis rate constant (K) and the kinetic order of degradation reactions under different pH. Subsequently, the pH where AZI was the most stable (pHm) was obtained from the lnk-pH curve, which was located at the lowest point of this curve.
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Cytotoxicity Assay
Human corneal epithelial (HCE-2) cells were cultured in Dulbecco's modified Eagle's medium (DMEM) which contained 10% (v/v) fetal calf serum, 100 IU/mL penicillin G and streptomycin, and 2 mM L-glutamine at 37 °C with 5% CO2 and air humidified atmosphere. HCE-2 cells were exposed to different concentrations of BZK solution, AZI-SH eye drops and commercial AZI eye drops diluted by medium for 24 h. Each concentration was tested in triplicates. DMSO (0.5%) served as the solvent control. The cell viability was then detected by MTT assay. MTT solution (20 μL, 5 mg/mL) was added into each well and incubated for 4 h. Then, the MTT-containing medium was removed and 200 μL of DMSO was added. The absorbance was measured at 490 nm by microplate reader (MD Spectramac M3, USA). The cell inhibition rate was calculated using the following Equation (1).
Cell inhibition rate (%) = (1− blank control blank sample
where Isample and Icontrol are the mean absorbance values of tested group and control group, respectively. Iblank is the absorbance value of the medium.
Results and Discussion
The cytotoxicity of AZI-SH eye drops toward human corneal epithelial cells in vitro was investigated via MTT assay. The results of MTT assay showed that AZI-SH eye drops had minimal toxicity in the range of 0.05-50 μg/mL, while BZK caused severe cytotoxicity. As illustrated in Figure  S1 , the cytotoxicity of these three groups increased significantly along with the increase in BZK concentration. The increase in toxicity was due to the addition of BZK. The IC50 of AZI-SH eye drops was 29.09 μg/mL, which was 1.35 times and 3.85 times higher than that of commercial AZI eye drops (21.60 μg/mL) and BZK solution (7.56 μg/mL), respectively. Table S3 . Influence of 3% azithromycin eye drops on rabbit papillary diameter (cm, n = 4). 
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